pharma · Opioid Use Disorder · Opioid Dependence
Indivior Pty
Indivior Pty Ltd
Indivior is a pharma organization headquartered in Richmond, USA. Primary therapeutic focus areas include Opioid Use Disorder, Opioid Dependence, Schizophrenia, Opioid Dependency, Opiate Dependence. NovaPharmaNews links
., Richmond, VA, US HQ
967 Employees
TGA registrant Type
Company details
- Status
- Public
- HQ
- ., Richmond, VA, US
- Employees
- 967
- Programs
- 39
- Drugs
- 19
- Patents
- 34
Buprenorphine soluble film
Phase 2 · small molecule · Opioid-related Disorders
Buprenorphine soluble film for Opioid-related Disorders is a Phase 2 program (small_molecule) at Indivior Pty Ltd with 1 ClinicalTrials.gov record(s).
Internal code RB-US-07-0002
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Indivior Pty Ltd
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Opioid-related Disorders
- Status
- completed
- Trials
- 1